ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0217

Where Are the Reporting Guidelines in Rheumatology? An Analysis of Their Use in over 850 Published Manuscripts

Aldo Barajas-Ochoa1, Antonio Cisneros-Barrios2, Manuel Ramirez-Trejo2 and Cesar Ramos-Remus3, 1Rutgers New Jersey Medical School., Richmond, VA, 2Universidad de Guadalajara, Guadalajara, Mexico, 3Unidad de Investigacion en Enfermedades Cronico-Degenerativas, Guadalajara, Mexico

Meeting: ACR Convergence 2022

Keywords: Education, OMERACT

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Professional Education Poster

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: EQUATOR-related reporting guidelines such as CONSORT, STROBE, and PRISMA have been said to promote clearer reporting of methods and results of a research manuscript for editors, peer reviewers, and readers. Our objectives were to assess: a) if 5 iconic rheumatology-focused journals encourage the use of these guidelines, and b) if the reporting guidelines were used in published research manuscripts of these journals.

Methods: This was an audit-type cross-sectional study of the journal’s instructions for authors and all original research manuscripts published in the 2019 printed versions of Annals of the Rheumatic Diseases (Ann Rheum Dis), Arthritis and Rheumatology (Arthritis Rheumatol), Arthritis Care and Research (Arthritis Care Res), Rheumatology, and Journal of Rheumatology (J Rheumatol).

The titles of research articles (no editorials, reviews, letters) were selected from the table of contents of each number. The full articles were then downloaded as PDF files using an institutional account. After corroborating that they were research articles, each PDF file was checked to assess whether the reporting guidelines were used, as per the appearance of keywords EQUATOR, CONSORT, STROBE, PRISMA, MOOSE, SPIRIT, STARD, TRIPOD, CARE, STREGA, and ARRIVE. Descriptive statistics were used.

Results: Four of the five assessed journals encouraged reporting guidelines in their instructions for authors’ information.

There were 899 selected and then reviewed manuscripts from the five journals: 176 (19%) from Ann Rheum Dis, 190 (21%) from Arthritis Rheumatol, 170 (19%) from Arthritis Care Res, 213 (24%) from Rheumatology, and 150 (17%) J Rheumatol.

Overall, reporting guidelines were used in 29 (3.2%) manuscripts: 9 CONSORT, 8 PRISMA, 7 STROBE, 2 SPIRIT, 2 ARRIVE, and 1 TRIPOD. These figures preclude association assessments.

Conclusion: The scarce use of reporting guidelines seems counterintuitive, considering they are intended to help authors report all relevant information, are free to use, easily accessible, customized for different study designs, and promoted by journals. Whether this is due to issues with the diffusion, awareness, acceptance, or perceived usefulness of the guidelines remains to be elucidated.


Disclosures: A. Barajas-Ochoa, None; A. Cisneros-Barrios, None; M. Ramirez-Trejo, None; C. Ramos-Remus, None.

To cite this abstract in AMA style:

Barajas-Ochoa A, Cisneros-Barrios A, Ramirez-Trejo M, Ramos-Remus C. Where Are the Reporting Guidelines in Rheumatology? An Analysis of Their Use in over 850 Published Manuscripts [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/where-are-the-reporting-guidelines-in-rheumatology-an-analysis-of-their-use-in-over-850-published-manuscripts/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/where-are-the-reporting-guidelines-in-rheumatology-an-analysis-of-their-use-in-over-850-published-manuscripts/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology